opc 21268 has been researched along with lixivaptan in 1 studies
| Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) | Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) |
|---|---|---|---|---|---|
| 133 | 3 | 6 | 80 | 10 | 26 |
| Protein | Taxonomy | opc 21268 (IC50) | lixivaptan (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.0172 | |
| Oxytocin receptor | Homo sapiens (human) | 0.519 | |
| Vasopressin V1a receptor | Rattus norvegicus (Norway rat) | 0.293 | |
| Vasopressin V1a receptor | Homo sapiens (human) | 0.1805 | |
| Vasopressin V2 receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
1 review(s) available for opc 21268 and lixivaptan
| Article | Year |
|---|---|
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |